Min Teo
Managing Partner & Co-Founder at Ethereal Ventures
San Francisco, California
Min Teo, Managing Partner & Co-Founder at Ethereal Ventures is an active investor based in San Francisco, California. This profile covers what Min Teo backs, at which stage, and how founders can reach out in 2026.
Min Teo partners with technical founders building global crypto platforms and protocols at Ethereal Ventures.
- Investor type
- VC
- Stages
- Seed
- Invests in
- Crypto & Web3
- Location
- San Francisco, California
- Typical check
- $250K
How to reach Min Teo
Angels and operators like Min Teo reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Min Teo
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Min Teo invest in?
Min Teo invests in Crypto & Web3, typically at Seed. Match your sector and stage, then reach out with a personalized pitch.
What stage does Min Teo invest at?
Min Teo typically invests at Seed. Lead with traction that fits the stage when you reach out.
What is Min Teo's typical check size?
Min Teo typically writes checks around $250K. Use it as a signal for whether your raise fits their stage.
How do I contact Min Teo?
Unlock Min Teo's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.